<DOC>
	<DOCNO>NCT00016588</DOCNO>
	<brief_summary>The purpose study look effectiveness tenofovir disoproxil fumarate ( TDF ) HIV-infected patient never take anti-HIV drug .</brief_summary>
	<brief_title>Tenofovir Disoproxil Fumarate ( TDF ) HIV-1 Patients Who Have Never Taken Anti-HIV Drugs</brief_title>
	<detailed_description>Patients receive TDF .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Have plasma viral load ( level HIV blood ) 10,000 copies/ml . Have CD4 count 50 cells/mm3 . Have negative pregnancy test . Agree use 2 form barrier birth control study 30 day afterwards . Are 18 65 year old . Exclusion Criteria Patients eligible study : Have treatment follow type antiHIV drug : nucleoside reverse transcriptase inhibitor , nucleotide reverse transcriptase inhibitor ( e.g. , adefovir dipivoxil TDF ) , protease inhibitor , nonnucleoside reverse transcriptase inhibitor . Have receive vaccination within 30 day study entry . Have new AIDSdefining illness diagnose within 30 day study entry . Are take follow : drug may cause kidney problem , include aminoglycoside antibiotic , cidofovir , cisplatin , foscarnet , intravenous ( IV ) amphotericin B , IV vancomycin , oral IV ganciclovir , valganciclovir ; probenecid ; chemotherapy ; steroid drug ; interleukin2 ; investigational drug . Are pregnant breastfeeding . Have difficulty taking , absorb , tolerate drug mouth , may show longterm nausea vomit . Abuse alcohol drug . Have cancer Kaposi 's sarcoma basal cell carcinoma . Have infection need injectable antibiotic within 15 day study entry . Have kidney bone disease . Have medical condition past treatment study investigator believe would make patient unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2002</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Adenine</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Organophosphorus Compounds</keyword>
</DOC>